These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2660253)

  • 21. Role of endogenous prostaglandins in gastric secretion and mucosal defense.
    Cohen MM
    Clin Invest Med; 1987 May; 10(3):226-31. PubMed ID: 3040310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of prostaglandins in gastric mucosal protection.
    Wilson DE
    Trans Am Clin Climatol Assoc; 1996; 107():99-113; discussion 113-4. PubMed ID: 8725564
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastroprotective role of glucocorticoid hormones during action of nonsteroidal anti-inflammatory drugs].
    Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2009 Mar; 95(3):250-61. PubMed ID: 19449781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alendronate induces gastric injury and delays ulcer healing in rodents.
    Elliott SN; McKnight W; Davies NM; MacNaughton WK; Wallace JL
    Life Sci; 1998; 62(1):77-91. PubMed ID: 9444970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of the gastroduodenal mucosa by prostaglandins.
    Johansson C; Aly A; Befrits R; Smedfors B; Uribe A
    Scand J Gastroenterol Suppl; 1985; 110():41-8. PubMed ID: 3895394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.
    Blandizzi C; Fornai M; Colucci R; Natale G; Lubrano V; Vassalle C; Antonioli L; Lazzeri G; Del Tacca M
    World J Gastroenterol; 2005 Jul; 11(26):4052-60. PubMed ID: 15996031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric adaptation: basic and clinical aspects.
    Konturek SJ; Konturek JW
    Digestion; 1994; 55(3):131-8. PubMed ID: 8174825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroduodenal mucosal protection.
    Allen A; Flemström G; Garner A; Kivilaakso E
    Physiol Rev; 1993 Oct; 73(4):823-57. PubMed ID: 8415927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some new aspects of gastric mucosal protection and damage.
    Bennett A
    Acta Physiol Hung; 1989; 73(2-3):179-83. PubMed ID: 2688358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandins: viable therapy in gastric ulceration.
    Janusz AG; Janusz AJ
    S D J Med; 1993 Feb; 46(2):45-7. PubMed ID: 8441926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroduodenal defence mechanisms.
    Flemström G; Turnberg LA
    Clin Gastroenterol; 1984 May; 13(2):327-54. PubMed ID: 6378442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage.
    Schoen RT; Vender RJ
    Am J Med; 1989 Apr; 86(4):449-58. PubMed ID: 2648824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of endothelial cell-derived nitric oxide synthase (eNOS) is increased during gastric adaptation to chronic aspirin intake in humans.
    Fischer H; Becker JC; Boknik P; Huber V; Lüss H; Neumann J; Schmitz W; Domschke W; Konturek JW
    Aliment Pharmacol Ther; 1999 Apr; 13(4):507-14. PubMed ID: 10215736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans.
    Scheiman JM; Elta GH
    Semin Arthritis Rheum; 1990 Oct; 20(2):121-7. PubMed ID: 2123561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellular and molecular mechanisms of the gastric mucosa: injury of the mucosa and the protective action of antacids].
    Tarnawski A
    Rev Gastroenterol Peru; 1995; 15(1):74-8. PubMed ID: 7537548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.